Literature DB >> 1124562

Fenfluramine in the treatment of hypertensive patients with refractory obesity.

M E Scott, P G Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1124562      PMCID: PMC2385486     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


× No keyword cloud information.
  19 in total

1.  PREVALENCE OF CHRONIC DISEASES AND DISTRIBUTION OF SELECTED PHYSIOLOGIC VARIABLES IN A TOTAL COMMUNITY, TECUMSEH, MICHIGAN.

Authors:  F H EPSTEIN; T FRANCIS; N S HAYNER; B C JOHNSON; M O KJELSBERG; J A NAPIER; L D OSTRANDER; M W PAYNE; H J DODGE
Journal:  Am J Epidemiol       Date:  1965-05       Impact factor: 4.897

2.  Antagonism of guanethidine and bretylium by various agents.

Authors:  M D DAY; M J RAND
Journal:  Lancet       Date:  1962-12-15       Impact factor: 79.321

3.  Effect of weight loss on blood pressure.

Authors:  J V SALZANO; R V GUNNING; T N MASTOPAULO; W W TUTTLE
Journal:  J Am Diet Assoc       Date:  1958-12

4.  The effect of weight reduction upon the blood-pressure of obese hypertensive women.

Authors:  A P FLETCHER
Journal:  Q J Med       Date:  1954-07

5.  A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.

Authors:  O J Follows
Journal:  Br J Clin Pract       Date:  1971-05

6.  Effects of two slimming drugs on sleep.

Authors:  I Oswald; H S Jones; J E Mannerheim
Journal:  Br Med J       Date:  1968-03-30

7.  A double-blind clinical trial of an appetite depressant, fenfluramine, in general practice.

Authors:  P Brodbin; C A O'Connor
Journal:  Practitioner       Date:  1967-05

8.  Current therapeutics. CCXLI. The present status of anorexiant drugs.

Authors:  L J Duncan; J F Munro
Journal:  Practitioner       Date:  1968-01

9.  A clinical trial of fenfluramine.

Authors:  J B Traherne
Journal:  Practitioner       Date:  1965-11

10.  Relation of body weight to development of coronary heart disease. The Framingham study.

Authors:  W B Kannel; E J LeBauer; T R Dawber; P M McNamara
Journal:  Circulation       Date:  1967-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.